Copyright: ©Author(s) 2026.
World J Psychiatry. Aug 19, 2026; 16(8): 119137
Published online Aug 19, 2026. doi: 10.5498/wjp.119137
Published online Aug 19, 2026. doi: 10.5498/wjp.119137
Table 2 Comparison of treatment adherence between both groups, n (%)/mean ± SD
| Indicator | Comorbidity group (n = 65) | Non-comorbidity group (n = 691) | t/χ2 value | P value |
| ASMES | 4.21 ± 1.35 | 6.89 ± 1.27 | 16.783 | < 0.001 |
| Treatment adherence grade (n) | 89.215 | < 0.001 | ||
| High adherence (7-8 scores) | 8 (12.3) | 356 (51.5) | - | - |
| Moderate adherence (4-6 scores) | 32 (49.2) | 275 (39.8) | - | - |
| Low adherence (0-3 scores) | 25 (38.5) | 60 (8.7) | - | - |
| Medication omission rate (%) | 28.35 ± 8.67 | 8.12 ± 3.45 | 23.564 | < 0.001 |
| Follow-up examination omission rate (%) | 32.18 ± 9.24 | 7.56 ± 2.89 | 25.127 | < 0.001 |
| Health behavior implementation rate (%) | 35 (53.8) | 587 (84.9) | 42.351 | < 0.001 |
- Citation: Dun WC, Xia Q, Wei ZQ, Li CB. Impact of comorbid depression on treatment adherence and long-term urinary function following surgery for benign prostatic hyperplasia. World J Psychiatry 2026; 16(8): 119137
- URL: https://www.wjgnet.com/2220-3206/full/v16/i8/119137.htm
- DOI: https://dx.doi.org/10.5498/wjp.119137